254 related articles for article (PubMed ID: 20400270)
21. Effect of Antifungal Treatment in a Diet-Based Murine Model of Disseminated Candidiasis Acquired via the Gastrointestinal Tract.
Kadosh D; Najvar LK; Bocanegra R; Olivo M; Kirkpatrick WR; Wiederhold NP; Patterson TF
Antimicrob Agents Chemother; 2016 Nov; 60(11):6703-6708. PubMed ID: 27572393
[TBL] [Abstract][Full Text] [Related]
22. In vivo pharmacodynamic characterization of anidulafungin in a neutropenic murine candidiasis model.
Andes D; Diekema DJ; Pfaller MA; Prince RA; Marchillo K; Ashbeck J; Hou J
Antimicrob Agents Chemother; 2008 Feb; 52(2):539-50. PubMed ID: 18070979
[TBL] [Abstract][Full Text] [Related]
23. Pharmacodynamics of echinocandins against Candida glabrata: requirement for dosage escalation to achieve maximal antifungal activity in neutropenic hosts.
Howard SJ; Livermore J; Sharp A; Goodwin J; Gregson L; Alastruey-Izquierdo A; Perlin DS; Warn PA; Hope WW
Antimicrob Agents Chemother; 2011 Oct; 55(10):4880-7. PubMed ID: 21807969
[TBL] [Abstract][Full Text] [Related]
24. [Successful treatment with caspofungin of an invasive candidosis resistant to liposomal amphotericin B in a neutropenic patient].
Rome A; André N; Michel A; Coze C; Gentet JC; Bernard JL
Arch Pediatr; 2006 Dec; 13(12):1556-7. PubMed ID: 17049216
[No Abstract] [Full Text] [Related]
25. Activity of aminocandin (IP960) compared with amphotericin B and fluconazole in a neutropenic murine model of disseminated infection caused by a fluconazole-resistant strain of Candida tropicalis.
Warn PA; Sharp A; Morrissey G; Denning DW
J Antimicrob Chemother; 2005 Sep; 56(3):590-3. PubMed ID: 16046462
[TBL] [Abstract][Full Text] [Related]
26. In vivo efficacy of anidulafungin and caspofungin against Candida glabrata and association with in vitro potency in the presence of sera.
Wiederhold NP; Najvar LK; Bocanegra R; Molina D; Olivo M; Graybill JR
Antimicrob Agents Chemother; 2007 May; 51(5):1616-20. PubMed ID: 17307976
[TBL] [Abstract][Full Text] [Related]
27. Combination of caspofungin or anidulafungin with antimicrobial peptides results in potent synergistic killing of Candida albicans and Candida glabrata in vitro.
Harris MR; Coote PJ
Int J Antimicrob Agents; 2010 Apr; 35(4):347-56. PubMed ID: 20106636
[TBL] [Abstract][Full Text] [Related]
28. Antifungal therapies in murine infections by Candida kefyr.
Sanchis M; Martin-Vicente A; Capilla J; Guarro J
Mycoses; 2016 Apr; 59(4):253-258. PubMed ID: 26857550
[TBL] [Abstract][Full Text] [Related]
29. Anidulafungin in the treatment of patients with invasive candidiasis.
Kett DH; Cubillos GF
Int J Antimicrob Agents; 2008 Nov; 32 Suppl 2():S99-S102. PubMed ID: 19013348
[TBL] [Abstract][Full Text] [Related]
30. Efficacy of caspofungin in invasive candidiasis and candidemia--de-escalation strategy.
Lichtenstern C; Nguyen TH; Schemmer P; Hoppe-Tichy T; Weigand MA
Mycoses; 2008; 51 Suppl 1():35-46. PubMed ID: 18471160
[TBL] [Abstract][Full Text] [Related]
31. The investigational agent E1210 is effective in treatment of experimental invasive candidiasis caused by resistant Candida albicans.
Wiederhold NP; Najvar LK; Fothergill AW; McCarthy DI; Bocanegra R; Olivo M; Kirkpatrick WR; Everson MP; Duncanson FP; Patterson TF
Antimicrob Agents Chemother; 2015 Jan; 59(1):690-2. PubMed ID: 25331706
[TBL] [Abstract][Full Text] [Related]
32. Efficacies of caspofungin and a combination of caspofungin and meropenem in the treatment of murine disseminated candidiasis.
Ozcan SK; Budak F; Willke A; Filiz S; Costur P; Dalcik H
APMIS; 2006 Dec; 114(12):829-36. PubMed ID: 17207082
[TBL] [Abstract][Full Text] [Related]
33. Seven-year trend analysis of nosocomial candidemia and antifungal (fluconazole and caspofungin) use in Intensive Care Units at a Brazilian University Hospital.
Girão E; Levin AS; Basso M; Gobara S; Gomes LB; Medeiros EA; Costa SF
Med Mycol; 2008 Sep; 46(6):581-8. PubMed ID: 19180727
[TBL] [Abstract][Full Text] [Related]
34. Quantitative PCR assay to measure Aspergillus fumigatus burden in a murine model of disseminated aspergillosis: demonstration of efficacy of caspofungin acetate.
Bowman JC; Abruzzo GK; Anderson JW; Flattery AM; Gill CJ; Pikounis VB; Schmatz DM; Liberator PA; Douglas CM
Antimicrob Agents Chemother; 2001 Dec; 45(12):3474-81. PubMed ID: 11709327
[TBL] [Abstract][Full Text] [Related]
35. Anidulafungin versus fluconazole for invasive candidiasis.
Reboli AC; Rotstein C; Pappas PG; Chapman SW; Kett DH; Kumar D; Betts R; Wible M; Goldstein BP; Schranz J; Krause DS; Walsh TJ;
N Engl J Med; 2007 Jun; 356(24):2472-82. PubMed ID: 17568028
[TBL] [Abstract][Full Text] [Related]
36. Efficacy of micafungin against deep-seated candidiasis in cyclophosphamide-induced immunosuppressed mice.
Ninomiya M; Mikamo H; Tanaka K; Watanabe K; Tamaya T
J Antimicrob Chemother; 2005 Apr; 55(4):587-90. PubMed ID: 15728144
[TBL] [Abstract][Full Text] [Related]
37. Efficacy of the echinocandin caspofungin against disseminated aspergillosis and candidiasis in cyclophosphamide-induced immunosuppressed mice.
Abruzzo GK; Gill CJ; Flattery AM; Kong L; Leighton C; Smith JG; Pikounis VB; Bartizal K; Rosen H
Antimicrob Agents Chemother; 2000 Sep; 44(9):2310-8. PubMed ID: 10952573
[TBL] [Abstract][Full Text] [Related]
38. Intermittent Dosing of Micafungin Is Effective for Treatment of Experimental Disseminated Candidiasis in Persistently Neutropenic Rabbits.
Petraitiene R; Petraitis V; Hope WW; Walsh TJ
Clin Infect Dis; 2015 Dec; 61 Suppl 6(Suppl 6):S643-51. PubMed ID: 26567283
[TBL] [Abstract][Full Text] [Related]
39. Micafungin combined with fluconazole, an effective therapy for murine blastoschizomycosis.
Serena C; Rodríguez MM; Mariné M; Pastor FJ; Guarro J
J Antimicrob Chemother; 2008 Apr; 61(4):877-9. PubMed ID: 18276603
[TBL] [Abstract][Full Text] [Related]
40. Candida and candidaemia. Susceptibility and epidemiology.
Arendrup MC
Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]